A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial
Abstract:Aims: Prevention of type 2 diabetes (T2DM) is a priority in healthcare, but there is a lack of evidence investigating how to effectively translate prevention research into a UK primary care setting. We assessed whether a structured education programme targeting lifestyle and behaviour change was effective at preventing progression to T2DM in people with prediabetes..
Materials and methods:44 General Practices were randomised to receive either standard care or a six hour group structured education programme wit… Show more
“…We have not systematically searched for more recent primary studies not included in the reviews considered here. However, the latest update from the DPP is in keeping with the results reviewed,43 as are the results of additional recent trials,44
45 including trials based in routine practice, where clinical benefits were found to be modest 4647 We excluded non-English language publications that we were unable to access (see figure 1).…”
ObjectivesTo review the clinical outcomes of combined diet and physical activity interventions for populations at high risk of type 2 diabetes.DesignOverview of systematic reviews (search dates April–December 2015).SettingAny level of care; no geographical restriction.ParticipantsAdults at high risk of diabetes (as per measures of glycaemia, risk assessment or presence of risk factors).InterventionsCombined diet and physical activity interventions including ≥2 interactions with a healthcare professional, and ≥12 months follow-up.Outcome measuresPrimary: glycaemia, diabetes incidence. Secondary: behaviour change, measures of adiposity, vascular disease and mortality.Results19 recent reviews were identified for inclusion; 5 with AMSTAR scores <8. Most considered only randomised controlled trials (RCTs), and RCTs were the major data source in the remainder. Five trials were included in most reviews. Almost all analyses reported that interventions were associated with net reductions in diabetes incidence, measures of glycaemia and adiposity, at follow-up durations of up to 23 years (typically <6). Small effect sizes and potentially transient effect were reported in some studies, and some reviewers noted that durability of intervention impact was potentially sensitive to duration of intervention and adherence to behaviour change. Behaviour change, vascular disease and mortality outcome data were infrequently reported, and evidence of the impact of intervention on these outcomes was minimal. Evidence for age effect was mixed, and sex and ethnicity effect were little considered.ConclusionsRelatively long-duration lifestyle interventions can limit or delay progression to diabetes under trial conditions. However, outcomes from more time-limited interventions, and those applied in routine clinical settings, appear more variable, in keeping with the findings of recent pragmatic trials. There is little evidence of intervention impact on vascular outcomes or mortality end points in any context. ‘Real-world’ implementation of lifestyle interventions for diabetes prevention may be expected to lead to modest outcomes.
“…We have not systematically searched for more recent primary studies not included in the reviews considered here. However, the latest update from the DPP is in keeping with the results reviewed,43 as are the results of additional recent trials,44
45 including trials based in routine practice, where clinical benefits were found to be modest 4647 We excluded non-English language publications that we were unable to access (see figure 1).…”
ObjectivesTo review the clinical outcomes of combined diet and physical activity interventions for populations at high risk of type 2 diabetes.DesignOverview of systematic reviews (search dates April–December 2015).SettingAny level of care; no geographical restriction.ParticipantsAdults at high risk of diabetes (as per measures of glycaemia, risk assessment or presence of risk factors).InterventionsCombined diet and physical activity interventions including ≥2 interactions with a healthcare professional, and ≥12 months follow-up.Outcome measuresPrimary: glycaemia, diabetes incidence. Secondary: behaviour change, measures of adiposity, vascular disease and mortality.Results19 recent reviews were identified for inclusion; 5 with AMSTAR scores <8. Most considered only randomised controlled trials (RCTs), and RCTs were the major data source in the remainder. Five trials were included in most reviews. Almost all analyses reported that interventions were associated with net reductions in diabetes incidence, measures of glycaemia and adiposity, at follow-up durations of up to 23 years (typically <6). Small effect sizes and potentially transient effect were reported in some studies, and some reviewers noted that durability of intervention impact was potentially sensitive to duration of intervention and adherence to behaviour change. Behaviour change, vascular disease and mortality outcome data were infrequently reported, and evidence of the impact of intervention on these outcomes was minimal. Evidence for age effect was mixed, and sex and ethnicity effect were little considered.ConclusionsRelatively long-duration lifestyle interventions can limit or delay progression to diabetes under trial conditions. However, outcomes from more time-limited interventions, and those applied in routine clinical settings, appear more variable, in keeping with the findings of recent pragmatic trials. There is little evidence of intervention impact on vascular outcomes or mortality end points in any context. ‘Real-world’ implementation of lifestyle interventions for diabetes prevention may be expected to lead to modest outcomes.
“…Eight hundred and eighty patients were enrolled in the cluster RCT from July 2009 to June 2011, with 447 patients (51%) in the intervention group and 433 (49%) in the standard care group 10. Those randomised to standard care received a booklet giving information on risk factors for T2DM and how physical activity and lifestyle change can be used to prevent or delay the disease.…”
Section: Methodsmentioning
confidence: 99%
“…The primary outcome of the Let's Prevent Diabetes randomised controlled trial (RCT) was progression to T2DM during 3 years. Overall, there was a non-significant 26% reduction in the risk of developing T2DM in the intervention arm compared with standard care (p=0.18) 10. A significant reduction in progression to T2DM was seen in the intervention arm compared with standard care when only those who attended all of the education sessions (ie, the initial 6 hours plus the two annual refresher sessions) were included in the analysis (LJ Gray, T Yates, J Troughton, et al .…”
ObjectivesPrevention of type 2 diabetes mellitus (TD2M) is a priority for healthcare systems. We estimated the cost-effectiveness compared with standard care of a structured education programme (Let's Prevent) targeting lifestyle and behaviour change to prevent progression to T2DM in people with prediabetes.DesignCost-effectiveness analysis alongside randomised controlled trial.Setting44 general practices in Leicestershire, England.Participants880 participants with prediabetes randomised to receive either standard care or a 6-hour group structured education programme with follow-up sessions in a primary care setting.Main outcome measureIncremental cost utility from the UK National Health Service (NHS) perspective. Quality of life and resource use measured from baseline and during the 36 months follow-up using the EuroQoL EQ-5D and 15D instruments and an economic questionnaire. Outcomes measured using quality-adjusted life years (QALYs) and healthcare costs calculated in 2012–2013 prices.ResultsAfter accounting for clustering and missing data, the intervention group was found to have a net gain of 0.046 (95% CI −0.0171 to 0.109) QALYs over 3 years, adjusted for baseline utility, at an additional cost of £168 (95% CI −395 to 732) per patient compared with the standard care group. The incremental cost-effectiveness ratio is £3643/QALY with an 86% probability of being cost-effective at a willingness to pay threshold of £20 000/QALY.ConclusionsThe education programme had higher costs and higher quality of life compared with the standard care group. The Let's Prevent programme is very likely to be cost-effective at a willingness to pay threshold of £20 000/QALY gained.Trial registration numberISRCTN80605705.
“…A recent large-scale randomised controlled trial to evaluate the effect of a type 2 diabetes prevention lifestyle intervention (Let's Prevent) in a UK community setting failed to show a statistically significant reduction in progression to type 2 diabetes at 3 years compared with normal care, 9 that is, it failed to do the thing that it was supposed to do. Retrospective re-analysis of the data did show a significant reduction in progression to diabetes in the subgroup of patients who engaged and then attended subsequent sessions, with the greatest benefit seen for the 29.1% of patients randomised to the intervention who attended all sessions.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.